D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 91 Citations 34,411 352 World Ranking 7260 National Ranking 3914

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Chemotherapy

His main research concerns Internal medicine, Surgery, Transplantation, Gastroenterology and Bone marrow. Many of his studies involve connections with topics such as Oncology and Internal medicine. His Transplantation study combines topics from a wide range of disciplines, such as Combination chemotherapy and Immunology, Lymphoma.

His Gastroenterology research is multidisciplinary, incorporating perspectives in Methotrexate, Incidence, Cumulative incidence, Adverse effect and Leukemia. His research in Bone marrow intersects with topics in Survival rate, Complication and Disease. His Cyclophosphamide research is multidisciplinary, incorporating elements of Myeloid leukemia and Marrow transplantation.

His most cited work include:

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group (1627 citations)
  • Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia (1233 citations)
  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers (860 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Surgery, Multiple myeloma, Transplantation and Oncology. His research on Internal medicine frequently links to adjacent areas such as Gastroenterology. William I. Bensinger works mostly in the field of Gastroenterology, limiting it down to concerns involving Methotrexate and, occasionally, Randomized controlled trial.

In his study, which falls under the umbrella issue of Surgery, Leukemia and Antibody is strongly linked to Bone marrow. William I. Bensinger combines subjects such as Neutropenia and Dexamethasone with his study of Multiple myeloma. In his research on the topic of Transplantation, Haematopoiesis, Granulocyte colony-stimulating factor, CD34 and Progenitor cell is strongly related with Immunology.

He most often published in these fields:

  • Internal medicine (76.72%)
  • Surgery (48.86%)
  • Multiple myeloma (38.67%)

What were the highlights of his more recent work (between 2013-2021)?

  • Internal medicine (76.72%)
  • Multiple myeloma (38.67%)
  • Oncology (38.05%)

In recent papers he was focusing on the following fields of study:

William I. Bensinger spends much of his time researching Internal medicine, Multiple myeloma, Oncology, Dexamethasone and Lenalidomide. His Internal medicine study frequently draws connections between adjacent fields such as Surgery. William I. Bensinger has included themes like Gastroenterology and Tolerability in his Multiple myeloma study.

His Gastroenterology research includes themes of Survival rate and Plasma cell leukemia. His work deals with themes such as Hematopoietic stem cell transplantation, Autologous transplantation, Neutropenia and Mantle cell lymphoma, which intersect with Oncology. His Dexamethasone research is multidisciplinary, incorporating perspectives in Newly diagnosed, Adverse effect, Pharmacology and Cyclophosphamide.

Between 2013 and 2021, his most popular works were:

  • Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations (186 citations)
  • Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma (153 citations)
  • Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. (147 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Chemotherapy

William I. Bensinger mainly investigates Internal medicine, Multiple myeloma, Lenalidomide, Oncology and Pomalidomide. Within one scientific family, he focuses on topics pertaining to Surgery under Internal medicine, and may sometimes address concerns connected to Mantle cell lymphoma. His Multiple myeloma study integrates concerns from other disciplines, such as Gastroenterology, Adverse effect, Survival rate and Dexamethasone.

He has included themes like Progression-free survival, Thalidomide and Clinical trial in his Lenalidomide study. His work in Oncology addresses subjects such as Hematopoietic stem cell transplantation, which are connected to disciplines such as Transplantation Conditioning. His Pomalidomide study combines topics in areas such as Regimen and Refractory Multiple Myeloma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie.
British Journal of Haematology (2003)

2732 Citations

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia

Rainer Storb;H. Joachim Deeg;John Whitehead;Frederick Appelbaum.
The New England Journal of Medicine (1986)

1553 Citations

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift.
The New England Journal of Medicine (2001)

1142 Citations

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger;Patrick Stiff;William Bensinger;Teresa Gentile.
The New England Journal of Medicine (2004)

1001 Citations

Antigen CD34+ marrow cells engraft lethally irradiated baboons.

R J Berenson;R G Andrews;W I Bensinger;D Kalamasz.
Journal of Clinical Investigation (1988)

859 Citations

Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor

WI Bensinger;CH Weaver;FR Appelbaum;S Rowley.
Blood (1995)

848 Citations

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller.
The New England Journal of Medicine (2012)

837 Citations

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.

C Anasetti;D Amos;P G Beatty;F R Appelbaum.
The New England Journal of Medicine (1989)

825 Citations

Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

W Bensinger;F Appelbaum;S Rowley;R Storb.
Journal of Clinical Oncology (1995)

808 Citations

Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.

RJ Berenson;WI Bensinger;RS Hill;RG Andrews.
Blood (1991)

785 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing William I. Bensinger

Rainer Storb

Rainer Storb

Fred Hutchinson Cancer Research Center

Publications: 327

Frederick R. Appelbaum

Frederick R. Appelbaum

Fred Hutchinson Cancer Research Center

Publications: 184

Claudio Anasetti

Claudio Anasetti

Fred Hutchinson Cancer Research Center

Publications: 180

Sergio Giralt

Sergio Giralt

Memorial Sloan Kettering Cancer Center

Publications: 179

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 167

Richard E. Champlin

Richard E. Champlin

The University of Texas MD Anderson Cancer Center

Publications: 167

Brenda M. Sandmaier

Brenda M. Sandmaier

Fred Hutchinson Cancer Research Center

Publications: 164

H. Joachim Deeg

H. Joachim Deeg

Fred Hutchinson Cancer Research Center

Publications: 146

Paul J. Martin

Paul J. Martin

Fred Hutchinson Cancer Research Center

Publications: 144

Olle Ringdén

Olle Ringdén

Karolinska Institute

Publications: 144

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 142

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 142

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 134

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 131

Ted Gooley

Ted Gooley

Fred Hutchinson Cancer Research Center

Publications: 129

Barry E. Storer

Barry E. Storer

Fred Hutchinson Cancer Research Center

Publications: 128

Trending Scientists

Andrew Berg

Andrew Berg

International Monetary Fund

Aditya Kalyanpur

Aditya Kalyanpur

Elemental Cognition

Eric A. Bier

Eric A. Bier

Palo Alto Research Center

Sami Sayadi

Sami Sayadi

Qatar University

Iñaki Mondragon

Iñaki Mondragon

University of the Basque Country

Pragna Patel

Pragna Patel

Centers for Disease Control and Prevention

Henry M. Kronenberg

Henry M. Kronenberg

Harvard University

Jean-Jacques Letesson

Jean-Jacques Letesson

University of Namur

Bernd Hoffmann

Bernd Hoffmann

Friedrich-Loeffler-Institut

Malcolm W. Wallace

Malcolm W. Wallace

University of Melbourne

Kai G. Schulz

Kai G. Schulz

Southern Cross University

David A. Lawrence

David A. Lawrence

New York State Department of Health

Joachim I. Krueger

Joachim I. Krueger

Brown University

Jon Morgenstern

Jon Morgenstern

Columbia University

Laura A. Baker

Laura A. Baker

University of Southern California

David Zagzag

David Zagzag

New York University

Something went wrong. Please try again later.